| abstract |
A method for determining the likelihood that an individual has increased risk of a Cardiovascular Event (CV) event comprises detecting, in a biological sample removed from an individual, biomarker values that each correspond to one of at least N biomarkers selected from Table 1 (defined in the specification), and determining the likelihood that the individual has increased risk for a CV event based on said biomarker values with N being 2 to 155 and one of the at least N biomarkers selected from Table 1 is CCL18. |